Quantitative Muscle Magnetic Resonance Outcomes in Patients With Duchenne Muscular Dystrophy: An Exploratory Analysis From the EMBARK Randomized Clinical Trial.
Saved in:
| Title: | Quantitative Muscle Magnetic Resonance Outcomes in Patients With Duchenne Muscular Dystrophy: An Exploratory Analysis From the EMBARK Randomized Clinical Trial. |
|---|---|
| Authors: | Vandenborne K; Department of Physical Therapy, University of Florida, Gainesville., Walter GA; Department of Physiology and Aging, University of Florida, Gainesville., Straub V; John Walton Muscular Dystrophy Research Centre, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom., Willcocks RJ; Department of Physical Therapy, University of Florida, Gainesville., Forbes SC; Department of Physical Therapy, University of Florida, Gainesville., Mercuri EM; Pediatric Neurology Institute, Catholic University and Nemo Pediatrico, Fondazione Policlinico Gemelli IRCCS, Rome, Italy., Muntoni F; The Dubowitz Neuromuscular Centre, NIHR Great Ormond Street Hospital Biomedical Research Centre, Great Ormond Street Institute of Child Health and Institute of Neurology, University College London, & Great Ormond Street Hospital Trust, London, United Kingdom., Ding K; Sarepta Therapeutics Inc, Cambridge, Massachusetts., Ennamuri S; Sarepta Therapeutics Inc, Cambridge, Massachusetts., Reid C; Roche Products Ltd, Welwyn Garden City, United Kingdom., Murphy AP; Roche Products Ltd, Welwyn Garden City, United Kingdom., Manfrini M; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Mendell JR; Sarepta Therapeutics Inc, Cambridge, Massachusetts.; Center for Gene Therapy, Nationwide Children's Hospital, Columbus, Ohio.; The Ohio State University, Columbus., Elkins JS; Sarepta Therapeutics Inc, Cambridge, Massachusetts., Rodino-Klapac LR; Sarepta Therapeutics Inc, Cambridge, Massachusetts. |
| Source: | JAMA neurology [JAMA Neurol] 2025 Jul 01; Vol. 82 (7), pp. 734-744. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589536 Publication Model: Print Cited Medium: Internet ISSN: 2168-6157 (Electronic) Linking ISSN: 21686149 NLM ISO Abbreviation: JAMA Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
